Analystreport

Kiniksa Pharmaceuticals Ltd (NASDAQ: KNSA) is now covered by analysts at Bank of America Corp. They set a "buy" rating and a $25.00 price target on the stock.

Kiniksa Pharmaceuticals, Ltd. - Class A Ordinary Shares  (KNSA) 
Last kiniksa pharmaceuticals, ltd. - class a ordinary shares earnings: 8/12 04:02 pm Check Earnings Report